Department of Cardiac Surgery, Montreal Heart Institute, Université de Montréal, 5000 Belanger St. (East), Montréal, QC, Canada.
J Cardiovasc Transl Res. 2010 Dec;3(6):652-62. doi: 10.1007/s12265-010-9198-2. Epub 2010 Jun 8.
Cardiac cell therapy has emerged as a controversial yet promising therapeutic strategy. Both experimental data and clinical applications in this field have shown modest but tangible benefits on cardiac structure and function and underscore that transplanted stem-progenitor cells can attenuate the postinfarct microenvironment. The paracrine factors secreted by these cells represent a pivotal mechanism underlying the benefits of cell-mediated cardiac repair. This article reviews key studies behind the paracrine effect related to the cardiac reparative effects of cardiac cell therapy.
心脏细胞疗法已经成为一种备受争议但又充满希望的治疗策略。该领域的实验数据和临床应用都表明,心脏结构和功能有适度但切实的改善,并强调移植的干细胞-祖细胞可以减轻梗塞后微环境的损伤。这些细胞分泌的旁分泌因子是细胞介导的心脏修复作用的关键机制。本文综述了心脏细胞疗法的心脏修复作用的旁分泌效应的相关关键研究。